ArticleThoracic cancer2023

Pretreatment eosinophil counts as a predictive biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Eiji Takeuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.